When was DHV Neuropathy founded?

DHV Neuropathy was founded in 1996.

Where is DHV Neuropathy located?

DHV Neuropathy is headquartered in Miami, United States.

Where does DHV Neuropathy rank among its competitors?

DHV Neuropathy ranks 156th amongst 159 active competitors, of which 6 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was First Person Group, which secured $1.27M in Jan, 2023.

Who are the top competitors of DHV Neuropathy?

DHV Neuropathy's top competitors include Procera Health, Quincy Bioscience and Lucid. Among them, First Person Group secured the most recent funding round in January, 2023.

DHV Neuropathy - 2026 Company Profile & Competitors

DHV Neuropathy is an unfunded company based in Miami (United States), founded in 1996. It operates as a Manufacturing and marketing a neuropathy care formula. DHV Neuropathy has not raised any funding yet. The company has 159 active competitors, including 6 funded and 5 that have exited. Its top competitors include companies like Procera Health, Quincy Bioscience and Lucid.

Company Details

DHV is engaged in manufacturing and marketing a proprietary neuropathy care formula. The company has one marketed product under the brand name DHV - Neuropathy Care. Ingredients used to manufacture DHV include alpha lipoic acid, gama linolenic acid and chromium picolinate. Benefits of DHV include increased blood flow to nerves, improve imbalance, reduce sensation of numbness, improve cardiac autonomic neuropathy, promotes antioxidant protection from glucotoxicity and reduce symptoms of painful neuropathy. As of Jan 2017, the company sells the product online.

Website: dhvneuropathy.net
Phone Number: +1 **********

Key Metrics

Founded Year

1996

Location

Miami, United States

Stage

Unfunded

Ranked

156^th among 159 active competitors

Similar Companies

Procera Health & 172 more

View DHV Neuropathy's full profile

DHV Neuropathy has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of DHV Neuropathy include Procera Health, Quincy Bioscience and Lucid. Here is the list of Top 10 competitors of DHV Neuropathy, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Procera Health 2005, Tampa (United States), Series B	Provider of nutritional products for brain health	$12.9M	-	37/100
2nd	Quincy Bioscience 2004, Madison (United States), Series B	Biotechnology company discovering and commercializing novel technologies for brain health	$5.18M	Capitala Group	32/100
3rd	Lucid 2015, Sydney (Australia), Unfunded	Manufactrures proprietary cognitive enhancer supplement	-	-	31/100
4th	Neuroscience 2000, New York (United States), Unfunded	Provider of professional grade dietary supplements for nervous, endocrine, and immune systems	-	-	30/100
5th	Recyte Therapeutics 2011, Alameda (United States), Early Stage	Online retailer of vitamins, supplements, lab tests, and health information	$9.9M	-	29/100
6th	Brain Armor 2015, Brookfield (United States), Unfunded	Brain health supplements for focus, memory, and long-term cognitive support	-	-	28/100
7th	Neuropathy Treatment Group 2010, Boise (United States), Unfunded	Nerve Renew: Complete nerve support for healthy nerve function	-	-	28/100
8th	First Person Group 2016, Los Angeles (United States), Seed	Provider of functional mushroom ingredients for mental health	$1.27M	Medbright	27/100
9th	Sevo Nutraceuticals 2012, Boston (United States), Seed	Online platform for slot games with deposit via pulsa options	$475K	VIC Technology Venture Development	26/100
10th	CogniBiome Therapeutics 2026, New Orleans (United States), Unfunded	Developer of probiotic supplements for gut health and cognitive function	-	-	26/100
156th	DHV Neuropathy 1996, Miami (United States), Unfunded	Manufacturing and marketing a neuropathy care formula	-	-	16/100